New Chlamydia and Gonorrhea Assays on the BD Viper(TM) LT System Receive FDA 510k Clearance

Assays bring an innovative solution to microbiology and molecular labs BALTIMORE, July 28, 2014 -- (Healthcare Sales & Marketing Network) -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company), (BDX) announced today it has received 510(k) c... Diagnostics, FDA BD , ProbeTec, Chlamydia, Gonorrhea
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news